18 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion.
(hh) Environmental Laws … , disposal, transport or handling of Hazardous Materials (collectively, “Environmental Laws”), (B) the Company and its Subsidiaries have all permits
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
research in the EU, are subject to significant regulatory controls.
Non-clinical studies are performed to demonstrate the health or environmental
F-3
EX-1.2
MREO
Mereo Biopharma Group Plc
5 Aug 21
Shelf registration (foreign)
4:33pm
reasonably be expected to result in debarment, suspension, or exclusion.
(hh) Environmental Laws. Except as described in the Registration Statement … (collectively, “Environmental Laws”), (B) the Company and its Subsidiaries have all permits, authorizations and approvals required under any applicable
6-K
EX-1.1
MREO
Mereo Biopharma Group Plc
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
) Environmental Laws. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus or would not, singly … , processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, “Environmental Laws”), (B
F-3
EX-1.2
MREO
Mereo Biopharma Group Plc
6 Oct 20
Shelf registration (foreign)
4:25pm
, and, to the Company’s knowledge, if issued or registered, is valid and enforceable.
(gg) Environmental Laws. Except as described in the Registration Statement … (collectively, “Environmental Laws”), (B) the Company and its Subsidiaries have all permits, authorizations and approvals required under any applicable
D
4rv4s m48a3yx
12 Jun 20
$70M in equity / options / securities to be acquired, sold $70M, 25 investors
12:18pm
6-K
EX-10.1
7vu49xht5 a1r1gi5os
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
6-K
EX-10.1
yz1cf0n6jnkzthgu
19 Feb 20
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor
9:32am
6-K
EX-10.1
hqu2a6zyk m305bxfghc
10 Feb 20
Current report (foreign)
7:20am
424B3
9rysda1xfom5z435n
20 Mar 19
Prospectus supplement
4:58pm
F-4/A
w43fkiwywfr
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
jw6ni iw4g7d
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.21
gsl87il
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.20
djq826dtjd26w
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.1
ohfhrrs
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.25
gyenttkls51l1ch6z
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.22
a1o3llmi vtn
25 Jan 19
Registration of securities (foreign)
12:00am
425
4l34svwo
6 Dec 18
Business combination disclosure
2:26pm
- Prev
- 1
- Next